Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
Crossref DOI link: https://doi.org/10.1186/s12931-017-0583-0
Published Online: 2017-05-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, Dave
D’Urzo, Anthony D.
Chuecos, Ferran
Muñoz, Anna
Garcia Gil, Esther
Funding for this research was provided by:
Almirall S.A.
Forest Laboratories LLC